White-Al Habeeb, N.M.A., Higgins, V., Wolska, A., Delaney, S.R., Remaley, A.T. and Beriault, D.R. (2023) The Present and Future of Lipid Testing in Cardiovascular Risk Assessment. Clinical Chemistry, 69, 456-469.
https://doi.org/10.1093/clinchem/hvad012

has been cited by the following article:

• TITLE: Isolated Systolic Hypertension in Geriatrics

  AUTHORS: Soumya Erri, Terry Oroszi

  KEYWORDS: Hypertension, Geriatric or Elderly or Adults, Types of Hypertension, Tests, First-Line Treatment, Drugs, Isolated Systolic Hypertension, Other Diseases

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.16 No.1, January 14, 2025

  ABSTRACT: Hypertension, often called the “silent killer”, is a major risk factor for heart attacks and strokes in the elderly. Its effective management is crucial to prevent damage to the heart, brain, and kidneys. Isolated systolic hypertension (ISH) is particularly critical in the elderly population. Cardiovascular risk factors, including pulse pressure and wave velocity, are closely associated with systolic blood pressure and influenced by arterial stiffness and wave reflections. Managing ISH is complex due to the potential negative effects of certain medications and individual variability in treatment response. This paper will address these issues, evaluating antihypertensive drugs, combination therapy, personalized treatment plans, and updated guidelines for managing ISH.